Karyopharm Therapeutics Inc. (KPTIQ) stock
KPTIQPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Karyopharm Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Karyopharm Therapeutics's ebitda for the twelve months ending Sep 30, 2020 was -$177.09M. For fiscal 2019 it was -$188.30M. The highest annual figure on record is -$10.23M in fiscal 2011.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -$188.30M | – |
| FY2018 | Dec 31, 2018 | -$179.15M | – |
| FY2017 | Dec 31, 2017 | -$129.83M | – |
| FY2016 | Dec 31, 2016 | -$110.02M | – |
| FY2015 | Dec 31, 2015 | -$118.44M | – |
| FY2014 | Dec 31, 2014 | -$75.52M | – |
| FY2013 | Dec 31, 2013 | -$33.81M | – |
| FY2012 | Dec 31, 2012 | -$15.77M | – |
| FY2011 | Dec 31, 2011 | -$10.23M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | -$46.87M | – |
| Q2 FY2020 | Jun 30, 2020 | -$40.08M | – |
| Q1 FY2020 | Mar 31, 2020 | -$47.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$43.02M | – |
| Q3 FY2019 | Sep 30, 2019 | -$39.16M | – |
| Q2 FY2019 | Jun 30, 2019 | -$41.44M | – |
| Q1 FY2019 | Mar 31, 2019 | -$64.68M | – |
| Q4 FY2018 | Dec 31, 2018 | -$57.26M | – |
| Q3 FY2018 | Sep 30, 2018 | -$48.97M | – |
| Q2 FY2018 | Jun 30, 2018 | -$34.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$38.77M | – |
| Q4 FY2017 | Dec 31, 2017 | -$39.28M | – |
| Q3 FY2017 | Sep 30, 2017 | -$30.88M | – |
| Q2 FY2017 | Jun 30, 2017 | -$29.57M | – |
| Q1 FY2017 | Mar 31, 2017 | -$30.10M | – |
| Q4 FY2016 | Dec 31, 2016 | -$26.99M | – |
| Q3 FY2016 | Sep 30, 2016 | -$25.56M | – |
See a number that looks wrong?